US Stock MarketDetailed Quotes
TVTX Travere Therapeutic
- 14.010
- -1.030-6.85%
Close Sep 27 16:00 ET
- 14.700
- +0.690+4.93%
Post 20:02 ET
1.07BMarket Cap-7826P/E (TTM)
14.900High13.972Low2.93MVolume14.180Open15.040Pre Close42.11MTurnover5.21%Turnover RatioLossP/E (Static)76.49MShares15.36052wk High70.76P/B788.95MFloat Cap5.12052wk Low--Dividend TTM56.31MShs Float37.040Historical High--Div YieldTTM6.17%Amplitude0.000Historical Low14.347Avg Price1Lot Size
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
Travere Therapeutic Stock Forum
Travere Therapeutics Announces Voluntary Pause of Enrollment in the Phase 3 HARMONY Study of Pegtibatinase Related to Commercial Manufacturing Scale-Up
SAN DIEGO, Sept. 26, 2024 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc., (NASDAQ:TVTX) today announced a voluntary pause of enrollment in the Phase 3 HARMONY Study evaluating pegtibatinase for the treatment of classical homocystinuria (HCU). The voluntary enrollment pause enables the Company to work to address ...
👀 stay tuned for updates on meeting outcomes
See 👇 for further info.
🚨 This Week’s AdCom:
$Iterum Therapeutics (ITRM.US)$ : Meeting ongoing 🤔
⇨ Sulopenem
‣ uUTI (Uncomplicated Urinary Tract Infection)
‣ AdCom: 9/9/24
🚨 Last Week’s PDUFAs:
$Travere Therapeutic (TVTX.US)$ : Approved 9/5 🎉
⇨ FILSPARI (Sparsentan)
‣ IgA nephropathy (IgAN)
‣ PDUFA: 9/5/24
$Avadel Pharmaceuticals (AVDL.US)$ : Awaiting decision 🤔
⇨ LUMRYZ (sodium oxybate)
‣...
🤔 no action even for AH.
No comment yet